Imagicaaworld Entertainment DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.56×0.07×0.93×1.00×2.22×
0.68×0.48×0.96×31.85×1.19×
9.0%4.8%21.1%6.6%54.2%
0.21×0.21×0.27×0.24×0.25×
1.40×1.40×1.51×1.38×4.71×
1.0%0.1%7.7%69.0%167.7%
0.1%0.1%7.5%105.1%151.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

IMAGICAA₹43.39

Imagicaaworld Entertainment Limited

· Consumer Services
₹ CrorePeersWONDERLADELTACORPNICCOPARMcap ₹2,455 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×2.221.000.930.070.56
Interest Burden (Pretax/EBIT) ×1.1931.850.960.480.68
EBIT Margin %54.176.5621.064.819.00
Asset Turnover ×0.250.240.270.210.21
Financial Leverage (Assets/Equity) ×4.711.381.511.401.40
ROE (5-step product, year-end total equity) %167.7068.987.650.051.01
ROE (owners' profit / average owners' equity) %151.87105.077.540.050.05
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.